ArticleACS medicinal chemistry letters2024

Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents.

Yan-Kai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.